“Your Skin Tells You” Campaign for Keratinocyte Cancers: When Individuals’ Selection Makes the Difference
Dermatology · 2023
DOI: 10.1159/000529368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology, 2023. Verfasst von Maria Concetta Fargnoli und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. Hauptthemen laut MEDLINE: Skin Neoplasms, Carcinoma, Squamous Cell, Basal Cell Carcinoma, Melanoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Prevention campaigns for skin cancers have focused primarily on melanoma, and over time there has been increasing awareness of the need to select the population to be screened to maximize program effectiveness.
Objectives
The objective of the study was to report the results of a free dermatological initiative, as part of an awareness campaign dedicated to keratinocyte cancers, targeting individuals pre-selected through a short questionnaire.
Methods
One day of dermatological consultations was held at 15 dermato-oncology referral centers during May 22–June 30, 2021. For selection, individuals answered a telephone interview consisting of 7 yes/no questions on risk factors. Demographics, clinical characteristics of suspicious tumors, and histopathologic diagnosis of excised lesions were collected. Suspicion rate, detection rate, and positive predictive values (PPVs) for any skin cancer, basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC), and melanoma were calculated.
Results
A total of 320 individuals (56.9% males; 43.1% females) with a median age of 69.6 (range 21–91) years qualified for the screening initiative. Overall, skin cancers and precancerous lesions were diagnosed in 65.9% of the patients. Suspicion rate was 28.7% for any skin cancer (92/320), 22.8% for BCC (73/320), 4.7% for cSCC (15/320), and 1.2% for melanoma (4/320). Detection rate was 23.4% for any skin cancer (PPV 93.7%), 18.1% for BCC (PPV 95.1%), 4.4% for cSCC (PPV 93.3%), and 0.9% for melanoma (PPV 75%).
Conclusions
Selection of individuals at high risk is a cost-effective approach for early detection campaigns for keratinocyte cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
- Dermatology Unit, Ospedale San Salvatore, L'Aquila, Italy.
- Department of Medical Sciences and Public Health, Dermatology, University Hospital of Cagliari, University of Cagliari, Cagliari, Italy.
- Dermatology, University of Siena, Siena, Italy.
- Dermatologia, Università Cattolica del Sacro Cuore, Rome, Italy.
- Dipartimento di Scienze Mediche e chirurgiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Zitieren
APA
Fargnoli, M. C., Antonetti, P., Atzori, L., Taddeucci, P., Di Stefani, A., Grandi, V., Lospalluti, L., Lacarrubba, F., Vaccari, S., Amerio, P., Fabbrocini, G., Rossi, M., Campione, E., Caposiena Caro, R. D., Moscarella, E., Rongioletti, F., Pellegrini, C., Peris, K., & Discab (2023). “Your Skin Tells You” Campaign for Keratinocyte Cancers: When Individuals’ Selection Makes the Difference. Dermatology. https://doi.org/10.1159/000529368
Vancouver
Fargnoli MC, Antonetti P, Atzori L, Taddeucci P, Di Stefani A, Grandi V, et al. “Your Skin Tells You” Campaign for Keratinocyte Cancers: When Individuals’ Selection Makes the Difference. Dermatology. 2023. doi:10.1159/000529368
BibTeX
@article{Fargnoli2023,
author = {Fargnoli, Maria Concetta and Antonetti, Paolo and Atzori, Laura and Taddeucci, Paolo and Di Stefani, Alessandro and Grandi, Vieri and Lospalluti, Lucia and Lacarrubba, Francesco and Vaccari, Sabina and Amerio, Paolo and Fabbrocini, Gabriella and Rossi, Mariateresa and Campione, Elena and Caposiena Caro, Raffaele Dante and Moscarella, Elvira and Rongioletti, Franco and Pellegrini, Cristina and Peris, Ketty and Discab},
title = {“Your Skin Tells You” Campaign for Keratinocyte Cancers: When Individuals’ Selection Makes the Difference},
journal = {Dermatology},
year = {2023},
doi = {10.1159/000529368}
}
EUVIMED